The renal distal convoluted tubule (DCT) is critical for the fine-tuning of urinary ion excretion and the control of blood pressure. Ion transport along the DCT is tightly controlled by posttranscriptional mechanisms including a complex interplay of kinases, phosphatases, and ubiquitin ligases. Previous work identified the transcription factor Prox-1 as a gene significantly enriched in the DCT of adult mice. To test if Prox-1 contributes to the transcriptional regulation of DCT function and structure, we developed a novel mouse model (NCCcre:Prox-1flox/flox) for an inducible deletion of Prox-1 specifically in the DCT. The deletion of Prox-1 had no obvious impact on DCT structure and growth independent whether the deletion was achieved in newborn or adult mice. Furthermore, DCT-specific Prox-1 deficiency did not alter DCT-proliferation in response to loop diuretic treatment. Likewise, the DCT-specific deletion of Prox-1 did not cause other gross phenotypic abnormalities. Body weight, urinary volume, Na+ and K+ excretion as well as plasma Na+, K+, and aldosterone levels were similar in Prox-1DCTKO and Prox-1DCTCtrl mice. However, Prox-1DCTKO mice exhibited a significant hypomagnesemia with a profound downregulation of the DCT-specific apical Mg2+ channel TRPM6 and the NaCl cotransporter (NCC) at both mRNA and protein levels. The expression of other proteins involved in distal tubule Mg2+ and Na+ handling was not affected. Thus, Prox-1 is a DCT-enriched transcription factor that does not control DCT growth but contributes to the molecular control of DCT-dependent Mg2+ homeostasis in the adult kidney.
The renal distal convoluted tubule (DCT) is crucial for the control of ion homeostasis and the regulation of arterial blood pressure . Although only 5–10% of the sodium (Na+) filtered at the glomerulus is reabsorbed in the DCT, the Na+ transport activity of the DCT is the highest of all nephron portions, which is reflected by a very high mitochondrial density in DCT cells. The Na+ transport in the DCT is driven by the basolateral Na+-K+-ATPase and critically depends on the activity of the thiazide-sensitive NaCl cotransporter (NCC) in the apical plasma membrane of DCT cells [28, 30]. The DCT is also important for the control of renal magnesium (Mg2+) excretion as the DCT is the sole site for active transcellular Mg2+ reabsorption along the nephron. The Mg2+ reabsorption in the DCT is mediated by the apical transient receptor potential cation channel subfamily M member 6 (TRPM6)  and modulated by the γ-subunit of the Na+-K+-ATPase encoded by the FXYD2 gene [2, 27].
Genetic diseases affecting the DCT evidence the significance of the DCT for the control of ion homeostasis and blood pressure . In Gitelman syndrome, loss-of-function mutations in NCC lead to an autosomal recessive renal tubulopathy characterized by renal salt-wasting with low blood pressure, hypokalemic alkalosis, hypocalciuria, and hypomagnesemia . Conversely, an inappropriate increase in NCC activity due to mutations in NCC-regulating with no lysine (K) kinases (WNK1 and 4) or ubiquitin ligase complexes (KLHL3, CUL3) causes salt-sensitive familial hyperkalemic hypertension (FHHt) with metabolic acidosis and hypercalciuria, also known as Gordon syndrome or pseudohypoaldosteronism type II (PHA II) [12, 28, 41]. Likewise, mutations in TRPM6 [36, 48] and FXYD2  cause renal tubulopathies with magnesium wasting and hypomagnesemia .
The last couple of years brought tremendous insights into the molecular signaling mechanism that control the function of the DCT. A complex network of various kinases, phosphatases, and ubiquitin ligases was shown to regulate the DCT function. For example, the STE20-related proline-alanine–rich kinase (SPAK) and the oxidative-stress-responsive 1 kinase (OSR1) are known to directly phosphorylate and thereby activate NCC . The activity of SPAK and OSR1 itself is controlled by the upstream kinases WNK1 and WNK4  that again are regulated via the ubiquitin ligase complex proteins kelch-like 3 (KLHL3) and cullin 3 (CUL3) [13, 41]. The abundance of NCC is also directly regulated by ubiquitinylation via Nedd4–2 and the upstream kinase Sgk1 . Phosphatases such as protein phosphatase 1 (PP1), 3 (PP3 or calcineurin), and 4 (PP4) can counteract the activity of the kinases and inactivate NCC . Similar to NCC, the activity of TRPM6 is also controlled by several kinases. For example, the stimulatory effect of the epidermal growth factor (EGF) on TRPM6 is thought to be mediated by both Src-Family Kinases and mitogen-activated kinases (MAPK) and their downstream mediator PI3-kinase . Likewise, AKT/PKB and Cdk5 were implicated in the insulin-dependent regulation of TRPM6 .
Despite this significant progress, we still lack a comprehensive understanding of the regulatory mechanisms that govern the DCT. In particular, we lack significant information about the transcriptional control mechanism. Genetic studies linked the hepatocyte nuclear factor 1 beta (HNF1b) and its cofactor PCBD1 to the regulation of TRPM6 [1, 20], but the role of other DCT-expressed transcription factors is less clear. Previously, we identified the transcription factor Prospero Homeobox 1 (Prox-1) as a gene that is about 100 times more abundant in the DCT than in in the sum of all other renal tubules of adult mouse kidney . Together with NCC and TRPM6, Prox-1 belongs to the 20 gene products most enriched in the mouse DCT suggesting a specific role in this tubule segment. Also in the adult rat kidney, Prox-1 appears to be predominately if not exclusively expressed in the DCT as indicated by a comprehensive database on RNAseq data from isolated renal tubules .
Prox-1 is a transcription factor containing an evolutionary conserved homeobox-prospero domain that binds DNA and RNA and allows transcriptional regulation of other genes. It plays an essential role during developmental processes such as cell proliferation, cell fate determination, and progenitor cell differentiation in numerous mammalian organs (lymphatic system, CNS, eye, heart, liver, and pancreas) [8, 10, 32, 49]. Moreover, alterations in Prox-1 expression have been associated with several human malignancies including hematological diseases; brain tumors; and carcinomas of colon, pancreas, and liver, and the biliary system [10, 32]. In the kidney, Prox-1 is highly expressed in distal tubules of the developing mouse kidney where it is involved in differentiation and outgrowth of the medullary part of the loop of Henle . As in the adult kidney, Prox-1 is enriched in the DCT [23, 33], we hypothesized that Prox-1 may contribute to the transcriptional control of DCT function. As a constitutive Prox-1 knockout is embryonically lethal , we developed a novel mouse model that allowed an inducible, DCT-specific deletion of Prox-1 in the adult kidney.
Material and methods
Mice with “floxed” alleles for Prox-1 were a kind gift from Dr. G. Oliver (Chicago, USA). In this conditional knockout mouse model, exons 2 and 3 of the Prox-1 gene are flanked by loxP sites. Cre recombinase mediated deletion of these two exons removes the homeodomain and Prox domain and renders Prox-1 transcriptionally inactive . To target specifically the DCT, a mouse model with a tamoxifen-inducible cre activity in the DCT was custom-made by the company Ozgene (Bentley, Australia). In these mice, the cre-ERT2 was introduced into the three prime untranslated region (3′-UTR) of the Slc12a3/NCC gene, where it is expressed using the same internal ribosomal entry site (IRES) as the Slc12a3/NCC gene (Fig. 1A). TdTomato-red reporter mice  were obtained from The Jackson Laboratories Repository. All experiments involving living animals were conducted in accordance with Swiss laws and approved by the veterinary administration of the Canton of Zurich (Kantonales Veterinäramt), Switzerland.
Tamoxifen induction was performed in male mice 1–2 weeks after weaning (i.e., at the age of 35–45 days). Tamoxifen (Sigma-Aldrich, T5648) was dissolved in EtOH: sunflower oil (1:10). A dose of 2 mg per day was administered to the mice via gastric gavage on 5 subsequent days, 6 weeks prior to the experiments. The same dosage and procedure were applied to breastfeeding mother mice to induce cre expression in the newborn offspring.
Plasma and urine ion measurement
Blood was sampled by puncture of the inferior vena cava of isoflurane-anesthetized animals. Whole blood was centrifuged for 10 min at 3000 g and plasma was removed subsequently.
Plasma Na+, K+, and Ca2+ measurement
Blood ions (Na+, K+, Ca2+) were measured with the ABL80Flex Blood Gas Analyzer (Radiometer, Copenhagen, Denmark).
Plasma and urine Mg2+ and PO4 3− measurement
Plasma and urine Mg2+ and PO43− measurements were performed by the Zurich Integrative Rodent Physiology (University of Zurich) using photometric methods (UniCel DxC 800, Beckman Coulter, Brea, CA, USA).
Urine Na+, K+, and Ca2+ measurement
Urine was collected for 24 h from mice kept individually in metabolic cages (Tecniplast S.p.A., Buguggiate, Italy). Urinary electrolytes (Na+, K+, Ca2+) were measured by flame photometry (EFOX 5053, Eppendorf, Hamburg, Germany). Urine creatinine was assessed by the Jaffe method.
Aldosterone, 11-deoxycorticosterone, and corticosterone measurement
Aldosterone, 11-deoxycorticosterone, and corticosterone were determined by ultra-performance liquid chromatography-MS/MS (UPLC-MS/MS) as described previously with minor adaptations  using an Agilent 1290 Infinity II UPLC coupled to an Agilent 6495 triple quadrupole mass spectrometer. Data acquisition and quantitative analysis was performed by MassHunter (Version B.10.0. Build 10.0.27, Agilent Technologies).
Kidney harvesting and tissue processing
The kidneys of isoflurane-anesthetized adult mice were fixed by retrograde abdominal aortic perfusion of 3% paraformaldehyde (PFA) followed by rinsing with 0.1 M phosphate buffer (pH 7.4, 300 mOsm) and paraffin embedding. The kidneys of 10-day-old isoflurane-anesthetized pups were immersion fixed with paraformaldehyde (PFA) 3% for 12–16 h, then incubated in 0.1 M phosphate buffer (pH 7.4, 300 mOsm) for 4 h and finally embedded in paraffin.
Western blot and quantitative reverse transcription PCR
For western blot analysis and RNA extraction, perfusion was performed with PBS (pH 7.4) via the left ventricle of the heart; kidneys were removed and frozen in liquid nitrogen.
Tissue blocks were sectioned at 4 μm on a standard rotary microtome (Microm HM355S, Thermo Fisher Scientific, Waltham, MA, USA). The Pathisto AS-2 automatic slide stainer (Pathisto GmbH, Garbsen, Germany) was utilized for deparaffination using Histo-clear and for tissue rehydration using serial ethanol washes. For epitope retrieval, slides were heated in 10 mM citrate buffer (pH 6.0) in a microwave (98 °C, 10 min). After blocking with 10% normal goat serum (10 min), the sections were incubated overnight in a humidified chamber at 4 °C with the primary antibodies. The dilutions of the previously generated und described primary antibodies are shown in supplementary table 1. Secondary antibodies (Cy3-conjugated goat-anti-rabbit IgG, catalogue code 111–165-144, dilution 1/1000 and FITC-conjugated goat-anti-mouse IgG, catalogue code 115–095-068, dilution 1/100, both from Jackson Immuno Research Laboratories, West Grove, PA) were applied for 2 h at room temperature and sections were finally mounted using DABKO-glycergel and coverslips. Images were acquired at a Leica DM6000 B fluorescence microscope on Leica DFC350 FX fluorescence monochrome digital camera (Leica Microsystems, 35578 Wetzlar, Germany).
Western blot analysis
Kidneys were homogenized in ice-cold lysis buffer (Mannitol 200 mM, HEPES 80 mM, KOH 41 mM) containing protease inhibitor (Complete Ultra, Roche) and phosphatase inhibitor (PhosSTOP, Roche) using MagNA Lyser Green Beads (Roche) and Precellys 24 tissue homogenizer (Bertin Instruments), 2 × 20 s (2000 g). The homogenized samples were centrifuged for 10 min (1700 g) and the protein-containing supernatant was removed and stored at − 80 °C.
SDS-PAGE and Western blot
Equal amounts of protein (25 μg) from kidney samples were denatured in Laemmli Buffer (SDS, β-mercaptoethanol, bromophenol blue, glycerol and 0.5 M Tris-HCl buffer, pH 6.8), separated by SDS-page, and electrophoretically transferred onto nitrocellulose membranes. The membranes were blocked with Odyssey Blocking solution (LI-COR Biosciences) (10 min) and then incubated at 4 °C for 16 h with the primary antibodies (see table 1 of supplementary data) diluted in Odyssey Blocking buffer: PBS (1:5). After repeated washes with PBS, blots were incubated at room temperature for 2 h with secondary antibodies (goat-anti-rabbit IRDye 800, product number 926-32211 and goat-anti-mouse IRDye 680, product number 926-32220, 1:20′000, both from LI-COR Biosciences), in Casein Blocking solution: H2O (1:10). Immunoreactive bands were visualized and quantified with the Odyssey IR imaging system and software (LI-COR Biosciences) and normalized for either β-actin or the total protein signal obtained by REVERT Total Protein Stain (LI-COR Biosciences).
RNA isolation and quantitative PCR
RNA isolation and cDNA generation from total kidney tissue
Total RNA from kidney tissue was isolated using Promega kit (SV Total RNA Isolation System, catalog number Z3100), according to the manufacturer’s protocol. cDNA was generated using Promega kit (GoScript™ Reverse Transcription System, catalog number A5000) as per the manufacturer protocol. For whole kidney tissue, cDNA was further diluted to 1:5 in H2O.
RNA isolation and cDNA generation from isolated DCTs
Manually microdissected tubules were frozen in RNA lysis buffer containing β-mercaptoethanol, and RNA was isolated using Absolutely RNA Nanoprep kit (Agilent Technologies, catalog number 400753), following manufacturer’s protocol. cDNA was generated using Sensifast cDNA Synthesis kit (Bioline, catalog number BIO65053), and undiluted cDNA was used for RT-qPCR.
Real-time quantitative PCR
Expression levels of the genes of interest were quantified by real-time quantitative PCR using Light Cycler II 480 (Roche). Real-time PCR reactions were prepared using 5.0 μl of LightCycler 480 SYBR Green I Master (Roche), 3.75 μl of RNase free water, 0.25 μl of each primer (100 μM), and 0.75 μl of cDNA (final reaction volume of 10 μl). Gene-specific primer sequences are listed in table 2 of supplementary data. Specificity of the primers was first tested in a standard PCR with subsequent separation of PCR products in a 2% agarose gel. Relative mRNA gene expression was measured after normalization to GAPDH gene expression (total kidney) and ribosomal RNA gene expression (isolated DCTs).
Manual microdissection of distal convoluted tubules
Manual microdissection of distal convoluted tubules was conducted according to a previously published protocol . After perfusion of anesthetized mice with MEM media (GibcoBRL, Ref number 11058021) via left ventricle, the kidney was sagittally cut into two halves and the medulla was excised. Cortex was sliced into 1-mm thin sections that were then incubated in a digestion solution containing 4 ml MEM, 5 mM glycine, 6 mg/ml trypsin inhibitor (Trypsin inhibitor from Glycine max, Sigma-Aldrich, T9128), and 250 μg/ml collagenase (Collagenase from Clostridium histolyticum, Sigma-Aldrich, C9891), pH 7.4 at 37 °C for 25 min without shaking. The digested cortex sections were subsequently washed with ice-cold HEPES solution (NaCl 125 mM, KCl 3 mM, MgSO4 1.2 mM, CaCl2 1 mM, KH2PO4 2 mM, glucose 5 mM, HEPES 32.2 mM), and the renal DCTs were manually microdissected under a stereomicroscope based on their distinct morphological characteristic.
Implantation of mini-osmotic pump
Loading mini-osmotic pumps
Bumetanide (Sigma-Aldrich, B3023) (dosage of 40 mg/kg body weight/day) and bromodeoxyuridine (Sigma-Aldrich, B5002) (dosage 40 mg/kg body weight/day) were dissolved in H2O: PEG300 (1:5) with incubation on a thermo shaker on 36 °C, 1000 rpm, overnight. Mini-osmotic pumps from Alzet® (model 2001, DURECT Corporation, Cupertino, CA, USA) with a filling volume of 200 μl and a pump delivery rate of 1 μl/h were used. One day prior to pump implantation, the mini-osmotic pumps were loaded with appropriate volume (200 μl) of the solution as directed by manufacturer using the provided needle. The loaded mini-osmotic pumps were primed in sterile NaCl 0.9% at 37 °C overnight according to the supplier’s instruction.
Surgical implantation in mice
Mice were anesthetized with isoflurane and buprenorphine 0.01 mg/kg body weight (Temgesic®, 0.3 mg/ml, Indivior Schweiz AG, 3015880). For implantation of the pump, mice were placed in a prone position. A skin incision (1–2 cm) was made across the neck and a subcutaneous pocket was created using blunt forceps. After inserting the pump into the subcutaneous pouch, the skin wound was closed with two surgical clips.
For semi-thin sectioning, kidneys were fixed by vascular perfusion with 3% PFA as described above and postfixed in the same fixative to which 1% glutaraldehyde was added. The tissue was embedded in epoxy resin (EPON) and semi-thin sections of 0.8 μm were cut with an ultramicrotome (Leica UltraCut E ultramicrotome). For staining, slides were incubated at 60 °C for 2 min in 0.5% toluidine blue (Merck, 11593) and 0.5% sodium tetraborate decahydrate (Sigma-Aldrich, S9640), diluted in water, followed by coverslip mounting with Entellan new (Merck 1079610100).
The fractional cortical tubular volume of DCT segments was assessed according to a previously described protocol . Paraffin sections of kidneys were immunostained with an antibody against NCC (table 1 of supplementary material) and images were taken from each kidney section with the × 10 objective of the fluorescence microscope. DCTs were identified according to the antibody-staining pattern and the fractional cortical tubular volumes for DCTs were determined using a planimetric point-counting method performed with a computerized image analysis system (Stereo Investigator, MBF Bioscience, Williston USA).
Unpaired two-tailed t test and 2-way ANOVA were used to compare the groups (GraphPad Prism, Version 8.0.2). Data are given as means ± SEM. Values were considered as significantly different when p < 0.05.
Development and characterization of a new mouse model for inducible DCT-specific gene targeting
For a DCT-specific deletion of Prox-1, we first developed and characterized a novel mouse model with a tamoxifen-inducible cre activity in the DCT (see “Material and methods”). Upon tamoxifen administration, these mice show a strong nuclear localization of the cre recombinase specifically in the DCT (Fig. 1B), comprising both DCT1 and DCT2 as identified by their characteristic staining pattern for NCC and calbindin D28K . Using a tdTomato-red reporter mouse line , we found that cre-mediated recombination is negligible without tamoxifen induction, but increases drastically in cortical tubules when tamoxifen is administered for 5 days. Higher magnifications showed that the cre-mediated recombination starts precisely at the transition from TAL to DCT and ends at the transition from DCT to CNT (Fig. 1C). Immunoblotting confirmed that the insertion of the cre-ERT2 in the 3′UTR of NCC does not interfere with NCC expression and phosphorylation (Fig. 1D, E). Thus, this new NCC-cre-ERT2 mouse model allows a timed gene targeting restricted to the DCT. Unlike to a recently published mouse model with constitutive cre expression under the control of the NCC promoter , the new mouse model does not show evidence for cre-mediated recombination in non-DCT cells. Similar observations were made by the group of Jim McCormick who just reported a similar NCC-cre-ERT2 mouse model generated by a similar gene-modification strategy as we employed .
Prox-1 is enriched in adult mouse DCT
Prox-1 mRNA expression was determined in manually dissected DCTs from both Prox-1DCTCtrl and Prox-1DCTKO mice as well as from total kidney homogenates from Prox-1DCTCtrl mice. Comparing Prox-1 mRNA abundance in isolated DCT segments (ctrl) and total kidney tissue (ctrl), Prox-1 mRNA transcript levels showed a 5–6-fold enrichment in the DCT (Fig. 2). In the Prox-1DCTKO mice, hardly any Prox-1 expression was detectable in the isolated DCTs, confirming the efficacy of the DCT-specific Prox-1 deletion in our mouse model (Fig. 2). Isolated DCTs were not contaminated with other tubular segments, confirmed by absent Slc12A1/NKCC2 and AQP2 gene expression.
No gross pathological characteristics in Prox-1DCT KO mice
Breeding of NCC-cre-ERT2 with floxed Prox-1 animals resulted in a normal Mendelian inheritance pattern. Cre-induction and excision of the Prox-1 gene in DCT cells were induced upon tamoxifen administration either immediately after birth or at the age of weaning. Independent from the time point of induction, all mice with DCT-specific Prox-1 deletion (Prox-1DCTKO) did not show a gross pathological phenotype. Body weight, food, and water intake and 24-h urine excretion were comparable among the genotypes (Table 1).
No effect of a Prox-1 deletion on DCT development and outgrowth
To address the question whether Prox-1 influences the outgrowth of the DCT during renal development, Prox-1 deletion was induced in newborn mice via tamoxifen gavage of the breastfeeding mother during the first 5 days after birth. So-treated mice were sacrificed 10 days and 6 weeks after birth and kidneys were collected for further analysis. Based on paraffin sections of kidneys immunostained with antibody against NCC, DCTs were identified and the fractional cortical tubular volume for DCTs was determined using a planimetric point-counting method (morphometry). Neither a change in kidney morphology nor in the cortical tubular DCT volume was observed in Prox-1DCTKO mice compared to Prox-1DCTCtrl mice both 10 days and 6 weeks after birth (Fig. 3A, B). Morphologic analysis of the renal cortex (epon semi-thin sections) in both control and Prox-1DCTKO mice revealed no structural abnormalities of the DCT epithelium in response to a genetic loss of Prox-1 (Fig. 3C).
Deletion of Prox-1 does not influence DCT cell proliferation rate in response to a 3-day treatment with bumetanide
To test whether Prox-1 is involved in epithelial remodeling processes of the DCT that occur in response to a loop diuretic treatment, bumetanide was applied continuously during 3 days. The simultaneous administration of bromodeoxyuridine (BrdU) allowed for the detection of DCT cell proliferation rate. After the bumetanide treatment, a significant increase in DCT cell proliferation rate was observed in the group that received bumetanide plus BrdU compared to the group that was treated with BrdU only (Fig. 4A). However, quantitative analysis of the percentage of proliferating DCT cells under the bumetanide treatment revealed no difference in the proliferation rate between Prox-1DCTKO versus Prox-1DCTCtrl mice (Fig. 4B).
Overt hypomagnesemia, but no other changes in plasma electrolytes and urinary ion excretion in Prox-1DCT KO mice
Analysis of plasma electrolytes revealed a significant hypomagnesemia in Prox-1DCTKO mice, whereas no differences in other plasma electrolyte concentrations (Na+, K+, Ca2+, phosphate) and plasma aldosterone, 11-dehydrocorticosterone and corticosterone levels between the knockout and control groups were detected (Table 1). Urinary ion excretion (Na+, K+, Ca2+, Mg2+) was similar in Prox-1DCTCtrl and Prox-1DCTKO mice (Table 1).
Decreased NCC abundance due to a loss of Prox-1 in the DCT
Deletion of Prox-1 in the DCT in adult mice for 6 weeks resulted in a significant downregulation of total NCC and phospho-NCC protein abundance in total kidney homogenates of Prox-1DCTKO compared to Prox-1DCTCtrl (Fig. 5A, B). Similar results were shown for NCC gene expression (Fig. 5C). Interestingly, downregulation of NCC mRNA was less pronounced at 1 week after tamoxifen induction (Fig. 2), suggesting that the downregulation of NCC at the mRNA level is not an immediate effect.
No change in ENaC protein expression in Prox-1DCT KO mice
Protein expression analysis for α-, β-, and ɣ-ENaC revealed no significant difference in kidneys of Prox-1DCTCtrl and Prox-1DCTKO mice for both the total/glycosylated and the cleaved forms of ENaC (Fig. 6A, B).
Reduced protein expression of the DCT-specific Mg2+ channel TRPM6 in Prox-1DCT KO mice
A significant reduction in the protein expression of the DCT-specific Mg2+ channel TRPM6 was observed in total kidney homogenates of Prox-1DCTKO mice (Fig. 7A, B). In parallel, TRPM6 mRNA expression was also significantly reduced (Fig. 8A). mRNA levels of other renal magnesium transporters and proteins involved in Mg2+ homeostasis (EGF, CNNM2, EGF, FXYD2, Cldn16, Cldn19, TRPM7, Slc41a1–3) in total kidney homogenates were not altered in Prox-1DCTKO mice compared to their control littermates (Fig. 8B–L).
Transcription factors are proteins that bind to particular DNA sequences in gene regulatory regions and control gene expression and activity . The human genome encodes about 1600 regulatory sequence-specific transcription factors that have been identified and functionally characterized . With the exception of the steroid receptors (e.g., the mineralocorticoid receptor), most studies addressing the role of transcription factors in the kidney focus on their significance during embryonic development and their regulatory function in nephrogenesis and differentiation of nephron progenitor cells . Accordingly, gene mutations in transcription factors have been associated with congenital renal malformations and inherited diseases, emphasizing their important role during renal embryogenesis. For example, mutations in the transcription factor hepatocyte nuclear factor 1 homeobox B (HNF1B) gene have been shown to cause renal malformations, hypomagnesemia, and maturity-onset diabetes of the young (MODY) [1, 20]. Part of this phenotype was suggested to be related to a transcriptional downregulation of the basolateral Kir4.1/Kir5.1 K+ channel in the DCT . In contrary to the evolving knowledge of the role of transcription factors during renal development, only little is known about transcriptional control and regulation of gene expression in the adult kidney. Interestingly, the DCT transcriptome established previously [7, 23, 33] revealed a high number of enriched DCT genes known to be involved in transcriptional regulation and growth control during renal development and/or tumorigenesis, suggesting that this “embryological” transcriptome contributes to the characteristic adaptation capacity and plasticity exhibited by the DCT in the adult stage.
Given its regulatory function in cell proliferation in other organs such as the retina , muscle tissue , central nervous system , and lymphatic tissue , we hypothesized that Prox-1 might play a role in DCT epithelium structural remodeling processes that occur in response to a loop diuretic treatment. However, after a 3-day treatment with bumetanide, no difference in the DCT cell proliferation rate was observed in the Prox-1DCTKO mice compared to the Prox-1DCTCtrl group. A direct effect of Prox-1 on DCT cell proliferation was therefore not verifiable. Consistently, fractional cortical DCT volume remained unchanged subsequent to a loss of Prox-1, also indicating that Prox-1 is not directly involved in structural epithelial remodeling processes of the DCT.
In the developing mouse kidney, Prox-1 was demonstrated to be highly expressed in distal renal tubules, contributing to the differentiation of the medullary part of the loop of Henle . Given that a main portion of the outgrowth of the NCC-positive rodent DCT takes place in the first 10 days perinatally [37, 38], we investigated the effect of a Prox-1 deletion in the DCT at this early time of life. Mice in which a Prox-1 deletion was introduced during the first 10 days after birth did not reveal any morphological renal abnormality and the cortical tubular DCT volume remained intact, indicating that a loss of Prox-1 in this period of nephron development does not affect DCT outgrowth. Hence, Prox-1 may be less important for the initial formation of the DCT, but rather contributes to the regulation of DCT function and ion transport at the full-grown stage.
The expression of NCC as the major sodium reabsorption pathway of the DCT was significantly decreased due to a loss of Prox-1, confirming that Prox-1 does play a modulatory role in DCT function and ion transport regulation. As no change in the cortical tubular DCT volume was observed in Prox-1DCTKO mice neither during renal development nor at adulthood, we assume that this NCC downregulation is not due to a loss of DCT epithelium surface, but due to a NCC downregulation on the cellular level, which occurs as a consequence of the genetic disruption of Prox-1. The underlying gene networks modified by Prox-1 and resulting in this NCC downregulation remain elusive. To date, the regulation of NCC expression and phosphorylation has been understood as a complex interplay of kinases, phosphatases and ubiquitin-ligases [13, 34, 41, 51]. Here, we support the concept that—in addition to the already known posttranslational regulatory mechanisms—transcription factors previously linked to developmental processes but not epithelial transport, may participate in the control of DCT function.
Although the abundance of NCC as the major sodium reabsorption pathway of the DCT is significantly reduced in Prox-1DCTKO mice, no functional consequences in renal sodium handling, especially no salt-wasting phenotype was observed. Consistently, NCC null mutations lead only to mild perturbation of sodium and fluid volume homeostasis in mice  and most human patients . As almost every nephron segment participates in renal sodium reabsorption, compensatory mechanisms in other tubular segments that counteract NCC downregulation in the DCT are very likely to occur, even though no change in ENaC protein expression was demonstrated in our study.
The DCT is also a key site for Mg2+ balance and reabsorbs 10% of filtered tubular Mg2+ in an active transcellular manner via the luminal Mg2+ channel TRPM6 [6, 28, 46]. With this, the DCT represents the predominant site of specifically regulated Mg2+ excretion and ultimately controls the amount of Mg2+ excreted in the urine, because no Mg2+ reabsorption occurs in downstream nephron segments . Altered DCT structure and function either due to a genetic loss of NCC in Gitelman syndrome or an inhibition of NCC activity by thiazide-like diuretics may relevantly influence Mg2+ homeostasis and cause renal Mg2+ wasting and hypomagnesemia in mice [25, 31] and human patients [9, 21, 35]. Others and we previously reported a distinct reduction of TRPM6 abundance in a NCC null mutant mouse model, most probably linked to a loss of a significant portion of the DCT epithelium [31, 38]. In the current study, no change in the tubular DCT volume in Prox-1DCTKO mice is observed. The reduced TRPM6 expression and hypomagnesemia can hence not be explained with a loss of TRPM6 expressing DCT epithelium. One can only speculate whether the hypomagnesemic phenotype and TRPM6 downregulation in the Prox-1DCTKO mouse model is due to a direct or indirect regulation of TRPM6 through Prox-1 or whether this occurs secondary due to reduced NCC expression and diminished transcellular sodium transport.
Surprisingly, urinary magnesium excretion was unaltered or even slightly reduced in Prox-1DCTKO mice despite an overt hypomagnesemia compared to the control group. This is consistent with findings in kidney-specific TRPM6 null mice, which show hypomagnesemia despite reduced urinary Mg2+ excretion . It is conceivable that the downregulation of TRPM6-dependent Mg2+ transport in DCT gets compensated by an upregulation of paracellular Mg2+ reabsorption in the TAL and PT .
In conclusion, we developed a new mouse model for an inducible gene targeting in the renal DCT. We used this mouse model to study the DCT-specific role of the transcription factor Prox-1. While previous studies on Prox-1 and other renal transcription factors focused mainly on their role during embryonic development, the present study shows that Prox-1 has an important role in the adult DCT by controlling TRPM6-dependent Mg2+ homeostasis. The study may set an important base for future studies addressing the functional involvement of this and possibly other DCT-enriched transcription factors in regulatory pathways governing kidney function.
Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC, Ledermann SE, Rees L, van't Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel GU, Ellard S, Bockenhauer D (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 5:1123–1131
Bindels RJM, Hoenderop JG, Xi Q (2009) Regulation of magnesium reabsorption in DCT. Pflugers Arch - Eur J Physiol 458(1):89–98
Bouchard M (2004) Transcriptional control of kidney development. Differentiation 72:295–306
Chubanov V, Ferioli S, Wisnowsky A, Simmons DG, Leitzinger C, Einer C, Jonas W, Shymkiv Y, Bartsch H, Braun A, Akdogan B, Mittermeier L, Sytik L, Torben F, Jurinovic V, van der Vorst EP, Weber C, Yildirim ÖA, Sotlar K, Schürmann A, Zierler S, Zischka H, Ryazanov AG, Gudermann T (2016) Epithelial magnesium transport by TRPM6 is essential for prenatal development and adult survival. Elife 5:e20914
Cornelius RJ, Sharma A, Su X, McMahon AP, Ellison DH, McCormick JA (2020) A novel distal convoluted tubule-specific tamoxifen-inducible Cre-recombinase driven by the NaCl cotransporter gene. FASEB J 34:1–1
Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA (2001) Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81:51–84
De Baaij JH, Groot Koerkamp MJ, Lavrijsen M, van Zeeland F, Meijer H, Holstege FC, Bindels RJ, Hoenderop JG (2013) Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg(2+) handling. Am J Physiol Renal Physiol 11:F1563–F1573
Dyer MA, Livesey FJ, Cepko CL, Oliver G (2003) Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nat Genet 34:53–58
Ellison DH (2000) Divalent cation transport by the distal nephron: insights from Bartter’s and Gitelman’s syndromes. Am J Physiol Renal Physiol 279:F616–F625
Elsir T, Smits A, Lindstrom MS, Nister M (2012) Transcription factor PROX1: its role in development and cancer. Cancer Metastasis Rev 31:793–805
Glover M, Mercier Zuber A, Figg N, O'Shaughnessy KM (2010) The activity of the thiazide-sensitive Na(+)-Cl(-) cotransporter is regulated by protein phosphatase PP4. Can J Physiol Pharmacol 88:986–995
Hadchouel J, Delaloy C, Faure S, Achard JM, Jeunemaitre X (2006) Familial hyperkalemic hypertension. J Am Soc Nephrol 17:208–217
Hadchouel J, Ellison DH, Gamba G (2016) Regulation of renal electrolyte transport by WNK and SPAK-OSR1 kinases. Annu Rev Physiol 78:367–389
Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G (2005) Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 37:1072–1081
Ignatieva EV, Levitsky VG, Kolchanov NA (2015) Human genes encoding transcription factors and chromatin-modifying proteins have low levels of promoter polymorphism: a study of 1000 genomes project data. Int J Genomics 2015:260159–260115. https://doi.org/10.1155/2015/260159
Kato K, Konno D, Berry M, Matsuzaki F, Logan A, Hidalgo A (2015) Prox1 inhibits proliferation and is required for differentiation of the oligodendrocyte cell lineage in the mouse. PLoS One 10(12):e0145334
Kim YM, Kim WY, Nam SA, Choi AR, Kim H, Kim YK, Kim HS, Kim J (2015) Role of Prox1 in the transforming ascending thin limb of Henle’s loop during mouse kidney development. PLoS One e0127429
Kivelä R, Salmela I, Nguyen Y, Petrova TV, Koistinen HA, Wiener Z, Alitalo K (2016) The transcription factor Prox1 is essential for satellite cell differentiation and muscle fibre-type regulation. Nat Commun 7:13124
Kompatscher A, de Baaij JHF, Aboudehen K, Hoefnagels APWM, Igarashi P, Bindels RJM, Veenstra GJC, Hoenderop JGJ (2017) Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease. Kidney Int 5:1145–1156
Konrad M, Schlingmann KP (2014) Inherited disorders of renal hypomagnesaemia. Nephrol Dial Transplant 29(suppl 4):iv63–iv71
Kuller L, Farrier N, Caggiula A, Borhani N, Dunkle S (1985) Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 122:1045–1059
Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, Chen X, Taipale J, Hughes TR, Weirauch MT (2018) The human transcription factors. Cell 172:650–665
Lee JW, Chou CL, Knepper MA (2015) Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J Am Soc Nephrol 11:2669–2677
Loffing J, Loffing-Cueni D, Valderrabano V, Kläusli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B (2001) Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 281(6):F1021–F1027
Loffing J, Vallon V, Loffing-Cueni D, Aregger F, Richter K, Pietri L, Bloch-Faure M, Hoenderop JG, Shull GE, Meneton P, Kaissling B (2004) Altered renal distal tubule structure and renal Na(+) and Ca(2+) handling in a mouse model for Gitelman’s syndrome. J Am Soc Nephrol 15:2276–2288
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133–140
Mayan H, Farfel Z, Karlish SJD (2018) Renal Mg handling, FXYD2 and the central role of the Na,K-ATPase. Physiol Rep 6:1–10
McCormick JA, Ellison DH (2015) Distal convoluted tubule. Compr Physiol 5:45–98
Meij IC, Koenderink JB, van Bokhoven H, Assink KF, Groenestege WT, de Pont JJ, Bindels RJ, Monnens LA, van den Heuvel LP, Knoers NV (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 26:265–266
Moes AD, van der Lubbe N, Zietse R, Loffing J, Hoorn EJ (2014) The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation. Pflugers Arch - Eur J Physiol 466:107–118
Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ (2005) Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115:1651–1658
Oliver G, Sosa-Pineda B, Geisendorf S, Spana EP, Doe CQ, Gruss P (1993) Prox1, a prospero-related homeobox gene expressed during mouse development. Mech Dev 44(1):3–16
Picard N, Trompf K, Yang CL, Miller RL, Carrel M, Loffing-Cueni D, Fenton RA, Ellison DH, Loffing J (2014) Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension. J Am Soc Nephrol 25:511–522
Ronzaud C, Loffing-Cueni D, Hausel P, Debonneville A, Malsure SR, Fowler-Jaeger N, Boase NA, Perrier R, Maillard M, Yang B, Stokes JB, Koesters R, Kumar S, Hummler E, Loffing J, Staub O (2013) Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension. J Clin Invest 123:657–665
Ryan MP, Devane J, Ryan MF, Counihan TB (1984) Effects of diuretics on the renal handling of magnesium. Drugs 28(suppl1):167–181
Schlingmann K, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth W, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–170
Schmitt R, Ellison DH, Farman N, Rossier BC, Reilly RF, Reeves WB, Oberbäumer I, Tapp R, Bachmann S (1999) Developmental expression of sodium entry pathways in rat nephron. Am J Physiol Renal Physiol 276(3):F367–F381
Schnoz C, Carrel M, Loffing J (2020) Loss of NCC impairs the outgrowth of the renal distal convoluted tubule, Nephrol Dial Transpl gfz172, https://doi.org/10.1093/ndt/gfz172
Schultheis PJ, Lorenz JN, Meneton P, Niema ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, Sholl GE (1998) Phenotype resembling Gitelman’s syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem 273:1–6
Simon DB, Nelson-Williams C, Johnson Bia M, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP (1996) Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutation sin the thiazide-sensitive NaCl cotransporter. Nat Genet 12:24–30
Sohara E, Uchida S (2015) Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder. Nephrol Dial Transplant 9:1417–1424
Strajhar P, Schmid Y, Liakoni E, Dolder PC, Rentsch KM, Kratschmar DV, Odermatt A, Liechti ME (2016) Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects. J Neuroendocrinol 28(3):12374. https://doi.org/10.1111/jne.12374
Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ (2009) EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 20:78–85
Trepiccione F, Soukaseum C, Iervolino A, Petrillo F, Zacchia M, Schutz G, Eladari D, Capasso G, Hadchouel J (2016) A fate-mapping approach reveals the composite origin of the connecting tubule and alerts on “single-cell”-specific KO model of the distal nephron. Am J Physiol Renal Physiol 311(5):F901–F906
Van der Wijst J, Belge H, Bindels RJM, Devuyst O (2019) Learning physiology from inherited kidney disorders. Physiol Rev 99(3):1575–1653
Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG (2004) TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 279:19–25
Wagner CA, Lükewille U, Valles P, Breton S, Brown D, Giebisch GH, Geibel JP (2003) A rapid enzymatic method for the isolation of defined kidney tubule fragments from mouse. Pflugers Arch - Eur J Physiol 446:623–632
Walder R, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Engelhardt RK, Carmi R, Sheffield VC (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171–174
Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98(6):769–778
Wigle JT, Chowdhury K, Gruss P, Oliver G (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 21:318–322
Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112
Open access funding provided by University of Zurich. The authors would like to thank Dr. G. Oliver (Chicago) for kindly providing the Prox-1flox mice. The authors also thank Günther Schütz (Heidelberg) and Stefan Berger (Groningen) for providing the antibody against the Cre recombinase. Finally, we thank Nadine Naegele from the ZIRP facility of the University of Zurich for magnesium and phosphate measurements.
Christina Schnoz is member of the UZH MD/PhD program. Johannes Loffing is supported by research funds from the Swiss National Centre for Competence in Research “Kidney.CH” and by a project grant from the Swiss National Science Foundation (310030_173276/1).
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Schnoz, C., Moser, S., Kratschmar, D.V. et al. Deletion of the transcription factor Prox-1 specifically in the renal distal convoluted tubule causes hypomagnesemia via reduced expression of TRPM6 and NCC. Pflugers Arch - Eur J Physiol 473, 79–93 (2021). https://doi.org/10.1007/s00424-020-02491-1
- Renal distal convoluted tubule (DCT)
- DCT adaptation
- Transcription factor Prox-1
- NaCl cotransporter (NCC)
- Transient receptor potential cation channel subfamily M member 6 (TRPM6)